Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank86
3Y CAGR+31.2%
5Y CAGR+28.9%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+31.2%/yr
vs +3.8%/yr prior
5Y CAGR
+28.9%/yr
Consistent
Acceleration
+27.4pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$25.00M-31.5%
2024$36.51M+36.8%
2023$26.69M+141.0%
2022$11.07M+474.4%
2021$1.93M-72.6%
2020$7.04M-46.8%
2019$13.24M+38.7%
2018$9.54M+134.2%
2017$4.07M+7.5%
2016$3.79M-